GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Circa Group AS (OSL:CIRCA) » Definitions » Cash-to-Debt

Circa Group AS (OSL:CIRCA) Cash-to-Debt : 944.68 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Circa Group AS Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Circa Group AS's cash to debt ratio for the quarter that ended in Dec. 2023 was 944.68.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Circa Group AS could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Circa Group AS's Cash-to-Debt or its related term are showing as below:

OSL:CIRCA' s Cash-to-Debt Range Over the Past 10 Years
Min: 8.39   Med: 2319.01   Max: No Debt
Current: 944.68

During the past 4 years, Circa Group AS's highest Cash to Debt Ratio was No Debt. The lowest was 8.39. And the median was 2319.01.

OSL:CIRCA's Cash-to-Debt is ranked better than
87.13% of 1538 companies
in the Biotechnology industry
Industry Median: 6.485 vs OSL:CIRCA: 944.68

Circa Group AS Cash-to-Debt Historical Data

The historical data trend for Circa Group AS's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Circa Group AS Cash-to-Debt Chart

Circa Group AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Cash-to-Debt
8.39 3,693.34 No Debt 944.68

Circa Group AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only No Debt No Debt No Debt No Debt 944.68

Competitive Comparison of Circa Group AS's Cash-to-Debt

For the Biotechnology subindustry, Circa Group AS's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Circa Group AS's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Circa Group AS's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Circa Group AS's Cash-to-Debt falls into.



Circa Group AS Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Circa Group AS's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Circa Group AS's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Circa Group AS  (OSL:CIRCA) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Circa Group AS Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Circa Group AS's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Circa Group AS (OSL:CIRCA) Business Description

Traded in Other Exchanges
Address
Karenslyst alle 53, Oslo, NOR, 0279
Circa Group AS is a biotechnology company. The company is engaged in converting waste biomass into advanced biochemical materials. Its Furacell production process takes abundant waste biomass and makes a platform molecule, levoglucosenone.

Circa Group AS (OSL:CIRCA) Headlines

No Headlines